{"name":"XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.","slug":"xellsmart-bio-pharmaceutical-suzhou-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOS2RGakEtZVoyYmVlY054WEVQYWpRS3dON2JaNGZRMEtkNTJTUkJLVm5TRHc1cTZtRUhReF9lcGVJY0ZLR1VfeHFzY2l2dC1MSEdLYWRGMzVHM092LVlFaUVvSnEzbG9FNlIyeUhpa0tNME8xZGVQT3VUVFJzbGo5QzFxMW9iTjRrYlF0bzd6S3RXVUxQY01nM0JidGRFdWFERW9ZYzl3blV3TFFuQkpVLVI1X01HdGczZjNpQ0JCeTgyQVNQLVdIUA?oc=5","date":"2025-06-03","type":"pipeline","source":"BioPharma APAC","summary":"XellSmart Advances Global Leadership in iPSC-Derived Cell Therapies for CNS Disorders - BioPharma APAC","headline":"XellSmart Advances Global Leadership in iPSC-Derived Cell Therapies for CNS Disorders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxPdXljQjNNODFEUjBMT3pNd3dHei1ldHFJeVRGa1NZcUYxaUJaX3NFUTlCaklZTDQwTEJ6MzlWMXlKRWFBRnF0Vzh2NFFoUGx6d28yNmdMY3Brc1lIQndPRi1QV18taU1MU3lZVkRiZ2hSd1hsV3JLWGpobE41RDRldzBPeFFMeUVFWGl1ejhxRjNWT3NjbmJaU1k5OTBxc3FUWWVKOV9yd3J2dWFaZUk0V1JCNXdyX3FWc0dNWlNmY3B3MzEzdjFybGx3aE8zc1lvUHFEUk1kOS1rd1RRV1p5NHgyVDQ1VFA4Vk1sSGtpdVVnZVJs?oc=5","date":"2025-05-26","type":"regulatory","source":"BioSpectrum Asia","summary":"China approves world's first XellSmart's Allogeneic iPSC-derived Regenerative Cell Therapy for Spinal Cord Injury - BioSpectrum Asia","headline":"China approves world's first XellSmart's Allogeneic iPSC-derived Regenerative Cell Therapy for Spinal Cord Injury","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxQYWU0bWhzaXhiOEMtTXFIOHAtdjkwcHdxSnAtZ09zZGxSMUd3Ym5jWEpock5fSzRXWHQzdEtLTGhRRXkxMjZhb2FOMHRjUjgzaDdJZHk3RWpxcXFkMHBGNk0zeEl5QlM4MnI4X242RGw0Nlk0UUE3NG9YYzFPVm5XZDA1YWFEaFdwUnpOOVI0YUt6amJXcDRQX2ZWaFl6NXNlRHV6cmgtVEFKSzk4eTgydlc3T0NhOUdGNW1QcDNHczgzY21HNm41V2Y0eEZDVHhfbHc?oc=5","date":"2025-04-16","type":"regulatory","source":"BioPharma APAC","summary":"XellSmart Receives IND Approval from FDA for iPSC-Derived Cell Therapy in Parkinson’s Disease - BioPharma APAC","headline":"XellSmart Receives IND Approval from FDA for iPSC-Derived Cell Therapy in Parkinson’s Disease","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}